Drawing for INTERCHIM

USPTO serial 79030785

INTERCHIM

Reviewed by CopyMark Law Group

Reg. 3831967Status 706Registered
Filing date
Status date
Registration date
Aug 10, 2010
Examiner
BOULTON, KELLY F
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with INTERCHIM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jill M. Pietrini, Esq.

Jill M. Pietrini, Esq. Sheppard Mullin Richter & Hampton LLP1901 Avenue of the Stars, Suite 1600Los Angeles, CA 90067-6017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical products, namely, chemical substances used to synthesize other chemical substances, chemical preparations used as synthesis intermediates, reactives for chemicals in the nature of chemical reagents not for medical use, chemical molecules in the nature of organic chemistry used in combinatorial chemistry for scientific research in the field of industry, science, pharmaceutical, photography, agriculture, horticulture, and forestry; biochemicals not for medical use, namely, consumable and reactive chemical preparations for chromatography, silica for chromatography columns, chemical preparations used as synthesis intermediates and reactives for chemicals in the nature of chemical reagents, biochemical catalysts and reactives for chemicals in the nature of chemical reagents in the field of live science, and chemical molecules for combinatorial chemistry; biological products for research in the fields of immunological, proteomics, biochemicals, genomics and cell biology, not for medical or veterinary use, namely, primary antibodies and antigens and secondary antibodies; biological products for research in the fields of immunologicals, proteomics, biochemicals, genomics and cell biology, not for medical or veterinary use, namely, DNA labelling kits comprising fluorochrome-labelled antibodies, buffers and desalting tool; biological products for research in the fields of immunologicals, proteomics, biochemicals, genomics and cell biology, not for medical or veterinary use, namely, biochemistry and molecular biology kits comprising DNA polymerase and stain buffers; biological products for research in the fields of immunologicals, proteomics, biochemicals, genomics and cell biology, not for medical or veterinary use, namely, biochemical kits comprising cross-linker chemicals used as probes to link proteins and buffers; biological products for research in the fields of immunologicals, proteomics, biochemicals, genomics and cell biology, not for medical or veterinary use, namely, protein A kits comprising affinity resins and buffers; biological products for research in the fields of immunologicals, proteomics, biochemicals, genomics and cell biology, not for medical or veterinary use, namely, protein G kits comprising affinity resins and buffers; biological products for research in the fields of immunologicals, proteomics, biochemicals, genomics and cell biology, not for medical or veterinary use, namely, assay kits comprising reagents and buffers; biological products for research in the fields of immunologicals, proteomics, biochemicals, genomics and cell biology, not for medical or veterinary use, namely, bicinchoninic acid assay kits comprising bicinchoninic reagents and protein standard; biological products for research in the fields of immunologicals, proteomics, biochemicals, genomics and cell biology, not for medical or veterinary use, namely, Bradford protein assay kits comprising coomassie reagent and protein standard; fluorescent biochemical reagents commonly known as probes for detecting and analyzing molecules used in protein and nuclear arrays using a variety of techniques including enzyme-linked immunosorbent assays (ELISA), blotting, cytometry, microscopy, and micro-arrays; and minerals for laboratory use and industrial use, namely, silicaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
May 8, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 23, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 11, 2021NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 11, 202171AGREGISTERED-SEC.71 ACCEPTED—
Jan 10, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 5, 2020ES71TEAS SECTION 71 RECEIVED—
Aug 1, 2017NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED—
Aug 1, 2017C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Aug 1, 2017REINREINSTATED—
Apr 28, 2017C71TCANCELLED SECTION 71—
Mar 20, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 27, 2017MAILPAPER RECEIVED—
Oct 20, 2016RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 26, 2016PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Aug 22, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 18, 2016ES75TEAS SECTION 71 & 15 RECEIVED—
May 18, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 23, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 23, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 7, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 7, 2010FIMPFINAL DISPOSITION PROCESSED—
Nov 10, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 10, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 25, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 5, 2010NPUBNOTICE OF PUBLICATION—
Apr 21, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 13, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 9, 2010ACECAMENDMENT FROM APPLICANT ENTERED—
Apr 9, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 29, 2010MAILPAPER RECEIVED—
Dec 14, 2009CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 11, 2009CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 24, 2009ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 24, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 23, 2009MAILPAPER RECEIVED—
Jun 18, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2009ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 2, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2009MAILPAPER RECEIVED—
Feb 9, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 30, 2009ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 30, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 26, 2009MAILPAPER RECEIVED—
Jul 22, 2008CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2008DOCKASSIGNED TO EXAMINER—
Jun 18, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 18, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 15, 2008OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 1, 2008OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 1, 2008OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 25, 2008MAILPAPER RECEIVED—
Sep 17, 2007CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Aug 18, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 18, 2007ALIEASSIGNED TO LIE—
Jul 27, 2007MAILPAPER RECEIVED—
Mar 15, 2007RFNTREFUSAL PROCESSED BY IB—
Feb 27, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 27, 2007RFRRREFUSAL PROCESSED BY MPU—
Feb 27, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 26, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2007DOCKASSIGNED TO EXAMINER—
Dec 1, 2006NWAPNEW APPLICATION ENTERED—
Nov 30, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance